Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Wiffen (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Fox (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), S. Elliott (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom). The impact of maintenance oral corticosteroids (OCS) on disease burden and type-2 inflammatory signal in the Wessex Severe Asthma Cohort (WSAC). 2678

Member's Comments

No comment yet.

Related content which might interest you: The impact of depression in patients with severe asthma (SA) in the Wessex Severe Asthma Cohort (WSAC) Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 The impact of obesity in patients with severe asthma in the Wessex Severe Asthma Cohort (WSAC) Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma Source: International Congress 2016 – Asthma management Year: 2016 Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE) Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA) Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Low grade systemic inflammation and lung function outcomes in European adults from the global asthma and allergy network of excellence (GA2LEN) follow-up survey Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthma Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Systemic inflammation, comorbidities and the outcome of adult-onset asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015